HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Cancer Mortality

Cancer mortality is a critical aspect of public health, reflecting the number of deaths attributed to various forms of cancer within a given population. Despite advancements in medical science and increased awareness, cancer continues to be a leading cause of mortality worldwide. The complexity of cancer lies in its diverse forms and the multitude of factors influencing its development. Factors such as genetics, lifestyle choices, environmental exposures, and age contribute to the incidence and progression of cancer. The impact of cancer on mortality rates varies across different regions and demographic groups. Efforts to reduce cancer mortality involve prevention, early detection, and advanced treatment modalities. Public health campaigns emphasize lifestyle modifications, such as maintaining a healthy diet, exercising regularly, and avoiding tobacco and excessive alcohol consumption. Routine screenings and early diagnosis play a pivotal role in improving survival rates, as timely intervention can significantly enhance treatment outcomes. In recent years, medical research has led to the development of innovative therapies, including targeted therapies and immunotherapies, offering new hope for patients facing various types of cancer. Access to quality healthcare services, cancer education, and awareness campaigns further contribute to reducing cancer mortality rates. While progress has been made in the fight against cancer, challenges persist, including disparities in healthcare access, late-stage diagnoses, and the emergence of new cancer types. Continued research, collaboration, and global initiatives are essential to further advance our understanding of cancer and enhance strategies to mitigate its impact on mortality.In conclusion, cancer mortality remains a formidable challenge in the realm of public health. Addressing this challenge requires a comprehensive approach encompassing prevention, early detection, and cutting-edge treatments, as well as continued efforts to promote health equity and access to quality healthcare for all.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp